Adrien Jacquot1, François Sirveaux2, Olivier Roche2, Luc Favard3, Philippe Clavert4, Daniel Molé2. 1. Orthopaedic & Traumatologic Surgery Department, Centre Chirurgical E. Gallé, Nancy, France. Electronic address: ad.jacquot@gmail.com. 2. Orthopaedic & Traumatologic Surgery Department, Centre Chirurgical E. Gallé, Nancy, France. 3. Orthopaedic & Traumatologic Surgery Department, Hopital Trousseaux, Tours, France. 4. Orthopaedic Surgery and Hand Surgery Center, Illkirch Graffenstaden, Strasbourg, France.
Abstract
BACKGROUND: In a retrospective multicenter study, we evaluated the efficiency and outcomes of the different therapeutic options for infection after reversed shoulder arthroplasty. METHODS: Thirty-two patients were reoperated on for infection after reversed shoulder arthroplasty between 1996 and 2011. The mean age was 71 (55-83) years. The involved implants were primary prostheses in 23 cases and revision prostheses in 9 cases. The average preoperative Constant score was 34 (11-69). Six of these patients needed 2 successive procedures. A total of 38 procedures were performed: débridement (13), 1-stage (5) or 2-stage revision (14), or implant removal (6). At last follow-up (mean, 36 months; range, 12-137 months), every patient had clinical, biologic, and radiographic evaluation. RESULTS: Infections were largely caused by coagulase-negative staphylococci (56%) and Propionibacterium acnes (59%). The complication rate was 26%. At last follow-up, 26 patients were free of infection (81%). The final Constant score was 46 (12-75). After débridement with implant retention, the mean Constant score was 51 (29-75), but the healing rate was only 54%. Implant revision (1 or 2 stage) led to better functional results than implant removal (46 vs. 25; P = .001), with similar healing rates (73% and 67%, respectively). Patients with low initial impairment (Constant score > 30) were not significantly improved by surgical treatment. CONCLUSION: Débridement is the less aggressive option but exposes patients to healing failure. It should be proposed as a first treatment attempt. Revision of the implant is technically challenging but preserves shoulder function, with no higher rate of residual infection compared with implant removal.
BACKGROUND: In a retrospective multicenter study, we evaluated the efficiency and outcomes of the different therapeutic options for infection after reversed shoulder arthroplasty. METHODS: Thirty-two patients were reoperated on for infection after reversed shoulder arthroplasty between 1996 and 2011. The mean age was 71 (55-83) years. The involved implants were primary prostheses in 23 cases and revision prostheses in 9 cases. The average preoperative Constant score was 34 (11-69). Six of these patients needed 2 successive procedures. A total of 38 procedures were performed: débridement (13), 1-stage (5) or 2-stage revision (14), or implant removal (6). At last follow-up (mean, 36 months; range, 12-137 months), every patient had clinical, biologic, and radiographic evaluation. RESULTS: Infections were largely caused by coagulase-negative staphylococci (56%) and Propionibacterium acnes (59%). The complication rate was 26%. At last follow-up, 26 patients were free of infection (81%). The final Constant score was 46 (12-75). After débridement with implant retention, the mean Constant score was 51 (29-75), but the healing rate was only 54%. Implant revision (1 or 2 stage) led to better functional results than implant removal (46 vs. 25; P = .001), with similar healing rates (73% and 67%, respectively). Patients with low initial impairment (Constant score > 30) were not significantly improved by surgical treatment. CONCLUSION: Débridement is the less aggressive option but exposes patients to healing failure. It should be proposed as a first treatment attempt. Revision of the implant is technically challenging but preserves shoulder function, with no higher rate of residual infection compared with implant removal.
Authors: Giulio Maria Marcheggiani Muccioli; Gazi Huri; Alberto Grassi; Tommaso Roberti di Sarsina; Giuseppe Carbone; Enrico Guerra; Edward G McFarland; Mahmut N Doral; Maurilio Marcacci; Stefano Zaffagnini Journal: Int Orthop Date: 2017-01-26 Impact factor: 3.075
Authors: Paul Siegert; Bernhard J H Frank; Sebastian Simon; Dominik Meraner; Alexandra Pokorny-Olsen; Julian Diepold; Christian Wurnig; Jochen G Hofstaetter Journal: Arch Orthop Trauma Surg Date: 2022-09-29 Impact factor: 2.928
Authors: Matthew Brown; Kelechi Eseonu; Will Rudge; Simon Warren; Addie Majed; Ian Bayley; Deborah Higgs; Mark Falworth Journal: Shoulder Elbow Date: 2019-04-09
Authors: Antonio Arenas-Miquelez; Lucas Arbeloa-Gutierrez; Filippo Familiari; Julio de Pablos Journal: Indian J Orthop Date: 2020-10-22 Impact factor: 1.251